AAAAAA

   
Results: 1-14 |
Results: 14
ACTIVITY OF FOTEMUSTINE IN MEDULLOBLASTOMA AND MALIGNANT GLIOMA XENOGRAFTS IN RELATION TO O-6-ALKYLGUANINE-DNA ALKYLTRANSFERASE AND ALKYLPURINE-DNA N-GLYCOSYLASE ACTIVITY
Authors: VASSAL G BOLAND I TERRIERLACOMBE MJ WATSON AJ MARGISON GP VENUAT AM MORIZET J PARKER F LACROIX C LELLOUCHTUBIANA A PIERREKAHN A POULLAIN MG GOUYETTE A
Citation: G. Vassal et al., ACTIVITY OF FOTEMUSTINE IN MEDULLOBLASTOMA AND MALIGNANT GLIOMA XENOGRAFTS IN RELATION TO O-6-ALKYLGUANINE-DNA ALKYLTRANSFERASE AND ALKYLPURINE-DNA N-GLYCOSYLASE ACTIVITY, Clinical cancer research, 4(2), 1998, pp. 463-468
ACTIVITY OF FOTEMUSTINE IN MEDULLOBLASTOMA AND MALIGNANT GLIOMA XENOGRAFTS IN RELATION TO O-6-ALKYLGUANINE-DNA ALKYLTRANSFERASE AND ALKYLPURINE-DNA N-GLYCOSYLASE ACTIVITY
Authors: VASSAL G BOLAND I TERRIERLACOMBE MJ WATSON AJ MARGISON GP VENUAT AM MORIZET J PARKER F LACROIX C LELLOUCHTUBIANA A PIERREKAHN A POULLAIN MG GOUYETTE A
Citation: G. Vassal et al., ACTIVITY OF FOTEMUSTINE IN MEDULLOBLASTOMA AND MALIGNANT GLIOMA XENOGRAFTS IN RELATION TO O-6-ALKYLGUANINE-DNA ALKYLTRANSFERASE AND ALKYLPURINE-DNA N-GLYCOSYLASE ACTIVITY, Clinical cancer research, 4(2), 1998, pp. 463-468
PRECLINICAL DEVELOPMENT OF CAMPTOTHECIN DERIVATIVES AND CLINICAL-TRIALS IN PEDIATRIC ONCOLOGY
Authors: VASSAL G PONDARRE C BOLAND I CAPPELLI C SANTOS A THOMAS C LUCCHI E IMADALOU K PEIN F MORIZET J GOUYETTE A
Citation: G. Vassal et al., PRECLINICAL DEVELOPMENT OF CAMPTOTHECIN DERIVATIVES AND CLINICAL-TRIALS IN PEDIATRIC ONCOLOGY, Biochimie, 80(3), 1998, pp. 271-280
DNA-TOPOISOMERASE-I, A NEW TARGET FOR THE TREATMENT OF NEUROBLASTOMA
Authors: VASSAL G PONDARRE C CAPPELLI C TERRIERLACOMBE MJ BOLAND I MORIZET J BENARD J VENUAT AM ARDOUIN P HARTMANN O GOUYETTE A
Citation: G. Vassal et al., DNA-TOPOISOMERASE-I, A NEW TARGET FOR THE TREATMENT OF NEUROBLASTOMA, European journal of cancer, 33(12), 1997, pp. 2011-2015
POTENT THERAPEUTIC ACTIVITY OF IRINOTECAN (CPT-11) AND ITS SCHEDULE DEPENDENCY IN MEDULLOBLASTOMA XENOGRAFTS IN NUDE-MICE
Authors: VASSAL G BOLAND I SANTOS A BISSERY MC TERRIERLACOMBE MJ MORIZET J SAINTEROSE C LELLOUCHTUBIANA A KALIFA C GOUYETTE A
Citation: G. Vassal et al., POTENT THERAPEUTIC ACTIVITY OF IRINOTECAN (CPT-11) AND ITS SCHEDULE DEPENDENCY IN MEDULLOBLASTOMA XENOGRAFTS IN NUDE-MICE, International journal of cancer, 73(1), 1997, pp. 156-163
TUMORIGENICITY OF CEREBELLAR PRIMITIVE NEURO-ECTODERMAL TUMORS IN ATHYMIC MICE CORRELATES WITH POOR-PROGNOSIS IN CHILDREN
Authors: VASSAL G TERRIERLACOMBE MJ LELLOUCHTUBIANA A VALERY CA SAINTEROSE C MORIZET J ARDOUIN P RIOU G KALIFA C GOUYETTE A
Citation: G. Vassal et al., TUMORIGENICITY OF CEREBELLAR PRIMITIVE NEURO-ECTODERMAL TUMORS IN ATHYMIC MICE CORRELATES WITH POOR-PROGNOSIS IN CHILDREN, International journal of cancer, 69(2), 1996, pp. 146-151
THERAPEUTIC ACTIVITY OF CPT-11, A DNA-TOPOISOMERASE-I INHIBITOR, AGAINST PERIPHERAL PRIMITIVE NEUROECTODERMAL TUMOR AND NEUROBLASTOMA XENOGRAFTS
Authors: VASSAL G TERRIERLACOMBE MJ BISSERY MC VENUAT AM GYERGYAY F BENARD J MORIZET J BOLAND I ARDOUIN P BRESSACDEPAILLERETS B GOUYETTE A
Citation: G. Vassal et al., THERAPEUTIC ACTIVITY OF CPT-11, A DNA-TOPOISOMERASE-I INHIBITOR, AGAINST PERIPHERAL PRIMITIVE NEUROECTODERMAL TUMOR AND NEUROBLASTOMA XENOGRAFTS, British Journal of Cancer, 74(4), 1996, pp. 537-545
MAIN DRUG-METABOLIZING ENZYME-SYSTEMS IN HUMAN NON-HODGKINS-LYMPHOMASSENSITIVE OR RESISTANT TO CHEMOTHERAPY
Authors: RIBRAG V MASSAAD L JANOT F MORIZET J GOUYETTE A CHABOT GG
Citation: V. Ribrag et al., MAIN DRUG-METABOLIZING ENZYME-SYSTEMS IN HUMAN NON-HODGKINS-LYMPHOMASSENSITIVE OR RESISTANT TO CHEMOTHERAPY, Leukemia & lymphoma, 18(3-4), 1995, pp. 303-310
IN-VIVO EFFECT OF THE COMBINATION OF TNF AND ADRIAMYCIN AGAINST A HUMAN BREAST CELL-LINE EXPRESSING THE MDR-PHENOTYPE
Authors: ZYAD A CAI ZZ MORIZET J LEGRES LG BENARD J CHOUAIB S
Citation: A. Zyad et al., IN-VIVO EFFECT OF THE COMBINATION OF TNF AND ADRIAMYCIN AGAINST A HUMAN BREAST CELL-LINE EXPRESSING THE MDR-PHENOTYPE, International journal of oncology, 7(5), 1995, pp. 1067-1072
INFLUENCE OF TUMOR SIZE ON THE MAIN DRUG-METABOLIZING ENZYME-SYSTEMS IN MOUSE COLON ADENOCARCINOMA CO38
Authors: MASSAAD L CHABOT GG TOUSSAINT C KOSCIELNY S MORIZET J BISSERY MC GOUYETTE A
Citation: L. Massaad et al., INFLUENCE OF TUMOR SIZE ON THE MAIN DRUG-METABOLIZING ENZYME-SYSTEMS IN MOUSE COLON ADENOCARCINOMA CO38, Cancer chemotherapy and pharmacology, 34(6), 1994, pp. 497-502
TEST DOSE-GUIDED ADMINISTRATION OF CISPLATIN IN AN ANEPHRIC PATIENT -A CASE-REPORT
Authors: RIBRAG V DROZ JP MORIZET J LECLERCQ B GOUYETTE A CHABOT GG
Citation: V. Ribrag et al., TEST DOSE-GUIDED ADMINISTRATION OF CISPLATIN IN AN ANEPHRIC PATIENT -A CASE-REPORT, Annals of oncology, 4(8), 1993, pp. 679-682
MAIN DRUG-METABOLIZING AND CARCINOGEN-METABOLIZING ENZYME-SYSTEMS IN HUMAN NONSMALL CELL LUNG-CANCER AND PERITUMORAL TISSUES
Authors: TOUSSAINT C ALBIN N MASSAAD L GRUNENWALD D PARISE O MORIZET J GOUYETTE A CHABOT GG
Citation: C. Toussaint et al., MAIN DRUG-METABOLIZING AND CARCINOGEN-METABOLIZING ENZYME-SYSTEMS IN HUMAN NONSMALL CELL LUNG-CANCER AND PERITUMORAL TISSUES, Cancer research, 53(19), 1993, pp. 4608-4612
MAIN DRUG-METABOLIZING ENZYME-SYSTEMS IN HUMAN BREAST-TUMORS AND PERITUMORAL TISSUES
Authors: ALBIN N MASSAAD L TOUSSAINT C MATHIEU MC MORIZET J PARISE O GOUYETTE A CHABOT GG
Citation: N. Albin et al., MAIN DRUG-METABOLIZING ENZYME-SYSTEMS IN HUMAN BREAST-TUMORS AND PERITUMORAL TISSUES, Cancer research, 53(15), 1993, pp. 3541-3546
SCREENING OF MAIN DRUG-METABOLIZING-ENZYMES IN MOUSE AND HUMAN COLON TUMORS
Authors: MASSAAD L DEWAZIERS I RIBRAG V JANOT F MORIZET J BEAUNE PH GOUYETTE A CHABOT GG
Citation: L. Massaad et al., SCREENING OF MAIN DRUG-METABOLIZING-ENZYMES IN MOUSE AND HUMAN COLON TUMORS, Bulletin du cancer, 80(5), 1993, pp. 397-407
Risultati: 1-14 |